Library Subscription: Guest
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections
Forum on Immunopathological Diseases and Therapeutics
SJR: 0.164 SNIP: 0.041 CiteScore™: 0.18

ISSN Print: 2151-8017
ISSN Online: 2151-8025

Archives: Volume 1, 2010 to Volume 7, 2016

Forum on Immunopathological Diseases and Therapeutics

DOI: 10.1615/ForumImmunDisTher.2013008345
pages 1-10

Growth Factor Signaling Regulates Breast Cancer Stem Cells

Noriko Gotoh
Division of Cancer Cell Biology, Cancer Research Institute, Kanazawa University, Kakuma-machi, Ishikawa, 920-1192 Japan


Accumulating evidence suggests that cancer stem cells−which make up only a small proportion of heterogeneous tumor cells−possess a greater ability to maintain tumor formation than other tumor cell types. Although the concept of cancer stem cells greatly impacts cancer biology and evokes a reconsideration of cancer treatment, the molecular mechanisms involved in the contribution of cancer stem cells to tumorigenesis remain obscure. We found that heregulin (HRG), a ligand for HER3/ErbB3, induced tumor sphere formation of a breast cancer stem cell (BCSC)-enriched population as well as in breast cancer cell lines. HRG-induced tumor sphere formation was reduced by treatment with inhibitors for phosphatidyl inositol 3-kinase (PI-3 kinase). Furthermore, we found that the expression of IL8, a regulator of self-renewal in BCSC-enriched populations, was induced by HRG through the activation of the PI3K/NF-κB pathway. These findings illustrate that HRG/ErbB3 signaling appears to maintain tumor sphere formation through a PI3K/NF-κB pathway in human breast cancer.